A Study of LY2334737 in Participants With Cancer That is Advanced and/or Has Spread

NCT01648764 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

73

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Solid Tumor
Solid Tumor
Metastatic Tumor

Interventions

DRUG: LY2334737

Sponsor

Eli Lilly and Company